Indian Railway Finance Corporation (IRFC) reported a revenue of ₹6,899 crore for the second quarter, marking a 2% increase year-on-year from ₹6,761 crore. The company's net profit rose by 4%, and it declared a dividend of ₹0.8. Meanwhile, Gland Pharma's revenue for the same period reached ₹1,406 crore, up 2.4% from ₹1,373 crore. Following the announcement of its Q2 results, Gland Pharma shares surged by 11%, with further reports indicating a 13% increase in intra-day trading, reaching ₹1,819.95 on the BSE. Procter & Gamble Health shares also saw a significant rise, climbing 8.5% to a 52-week high of ₹5,730.75 per share.